References
1. Бокерия Л. А., Асланиди И. П., Беришвили И. И. и др. Оценка эффективности трансмиокардиальной лазерной реваскуляризации с помощью синхронизированной с электрокардиографией однофотонной эмиссионной компьютерной томографии и позитронной эмиссионной томографии // Бюлл. НЦССХ им. А. Н. Бакулева РАМН. - 2004. - Т. 5, № 4. - С. 105-115.
2. Бокерия Л. А., Беришвили И. И., Бузиашвили Ю. И., Сигаев И. Ю. Трансмиокардиальная лазерная реваскуляризация. - М.: Изд-во НЦССХ им. А. Н. Бакулева РАМН, 2001.
3. Бокерия Л. А., Ло П. К., Беришвили И. И. и др. Первый клинический опыт применения аллогенных скелетных миобластов для лечения пациентов с ишемической кардиомиопатией // Бюлл. НЦССХ им. А. Н. Бакулева РАМН. - 2004. - Т. 5, № 4. - С. 142-151.
4. Васильев М. Г., Снетков А. И., Цуканов В. Е. и др. Теоретическое обоснование использования биокомпозиционного материала «Остеоматрикс» в лечении детей и подростков с костной патологией // Детская хир. - 2006. - № 2. - С. 44-49.
5. Вахромеева М. Н. Отбор больных и оценка результатов трансмиокардиальной лазерной реваскуляризации с помощью методов ядерной медицины: Дис. … д-ра биол. наук. - М., 2004.
6. Грудянов А. И., Панасюк А. Ф., Ларионов Е. В., Бякова С. Ф. Использование биокомпозиционного остеопластического материала «Алломатрикс-имплант» при хирургическом лечении воспалительных заболеваний парадонта // Парадонтология. - 2003. - Т. 4, № 29. - С. 39-43.
7. Иванов С. Ю., Кузнецов Р. К., Чайлахян Р. К. и др. Перспективы применения в стоматологии материалов «Биоматрикс» и «Алломатрикс-имплант» в сочетании с остеогенными клетками-предшественниками костного мозга // Клин. имплантол. и стоматол. - 2000. - № 3-4 (17-18). - С. 37-40.
8. Кнышов Г. В. Коронарная хирургия: реалии и перспективы // Лiкування та дiагностика». - 1996. - № 3. - С. 28.
9. Потапов И. В., Крашенинников М. Е., Онищенко Н. А. Клеточная кардиомиопластика // Вест. трансплантол. и искусств. органов. - 2001. - № 2. - С. 46-54.
10. Ржанинова А. А., Горностаева С. Н., Гольдштейн Д. В. и др. Мезенхимальные стволовые клетки из фетального и донорского костного мозга человека: получение и сравнительная характеристика // Бюлл. эксперим. биол. и мед. - 2003 (Приложение). - С. 39-43.
11. Al-Radi O., Rao V., Li R. et al. Cardiac cell transplantation: closer to bedside // Ann. Thorac. Surg. - 2003. - Vol. 75. - P. S674-677.
12. Asahara T., Murohara T., Sullivan A. et al. Isolation of putative progenitor endothelial cells for angiogenesis // Science. - 1997. - Vol. 275. - P. 964-967.
13. Assmus B., Schachinger V., Teupe C. et al. Transplantation of Progenitor Cell and Regenerotion Enhancement in acute Myocardial Infarction (TOPCARE-AMI) // Circulation. - 2002. - Vol. 106. - P. 3009-3017.
14. Assmus B., Urbich C., Aichere A. et al. HMG-CoA reductase inhibitors reduce senescence and increase proliferation of endothelial progenitor cells via regulation of cell Cyclo regulatory genes // Circ. Res. - 2003. - Vol. 92. - P. 1049-1055.
15. Barandon L., Couffinhal T., Dufourcq P. et al. A novel angiogenic factor: promises for cardiac repair // Eur. J. Cardiothorac. Surg. - 2004. - Vol. 25. - P. 76-83.
16. Barbash J., Chouraqui P., Baron I. et al. Systemic delivery of bone marrow-derived mesenchymal stem cells to the infarcted myocardium. Feasibility, cell migration and body distribution // Circulation. - 2003. - Vol. 108. - P. 863-868.
17. Bauernschmitt R., Krane M., Wottke M. et al. Cardiac reoperation in octogerians // Interact. Cardiovasc. Surg. - 2007. - Vol. 6 (Suppl. 3). - P. S277.
18. Bikfalvi A., Han Z. Angiogenic factors are hematopoietic factors and vice versa // Leukemia. - 1994. - Vol. 8. - P. 523-529.
19. Bonaros N., Rauf R., Wolf D. et al. Intramyocardial delivery of angiopoietic progenitor cells improves cell survival and reduces apoptosis of skeletal myoblast transplantation in a model of ischemic heart failure // Interact. Cardiovasc. Thorac Surg. - 2006. - Vol. 5 (Suppl. 9). - P. S189.
20. Branca P., MeGaw P., Light R. et al. Factors associated with prolonged mechanical ventilation following coronary artery bypass surgery // Chest. - 2001. - Vol. 119. - P. 537-546.
21. Brehm M., Zeus T., Strauer B. et al. Stem cells - clinical application and perspectives // Herz. - 2002. - Vol. 27. - P. 611-620.
22. Bridges C., Horvath K., Nugent W. et al. The Society of Thoracic Surgeons Practice guideline Series: Transmyocardial laser revascularization // Ann. Thorac. Surg. - 2004. - Vol. 77. - P. 1494-1502.
23. Chachques J., Carpentier A. Cellular myoplasty: what are we really trying to achieve? // J. Thorac. Cardiovasc. Surg. - 2002. - Vol. 123. - P. 583-584.
24. Cikirikcioglu M., Pfister R., Pektok E. et al. Towards slow degradable polymer grafts: testing of co-polymer PDS-PLA grafts in the systemic arterial circulation of the rat // Interact. Cardiovasc. Surg. - 2007. - Vol. 6 (Suppl. 3). - P. S245.
25. Di Mauro M., Iaco A., Contini M. et al. Reoperative coronary artery bypass grafting: analysis of early and late outcomes // Ann. Thorac. Surg. - 2005. - Vol. 79. - P. 81-87.
26. Dib N., McCarthy P., Campbell A. et al. Safety and feasibility of autologous myiblast transplantation in patients with ischemic cardiomyopathy: interim results from the United States experience (Abstract 2291) // Amer. Heart Assoc. Sci. Session. - 2002.
27. Doty J. R., Salazar J. D., Fonger J. D. et al. Reoperative MIDCAB grafting: 3-year clinical experience // Eur. J. Cardiothorac. Surg. - 1998. - Vol. 13. - P. 641-649.
28. Eifert S., Lohse P., Rasch A. et al. Atherosclerosis progression after primary CABG: gene polymorphisms as risk factors for adverse events // Interact. Cardiovasc. Thorac. Surg. - 2006. - Vol. 5 (Suppl. 2). - P. S188.
29. El Oakley R., Ooi O., Bongso A. et al. Myocyte transplantation for myocardial repair: a few good cells can mend a broken heart // Ann. Thorac. Surg. - 2001. - Vol. 71. - P. 1724-1733.
30. Eschenhagen T., Zimmermann W. H. Engineering myocardial tissue // Circ. Res. - 2005. - Vol. 97, № 12. - P. 1220-1231.
31. Fuchs S., Baffour R., Zhou Y. et al. Transendocardial delivery of autologous bone marrow enhances collateral perfusion and regional function in pigs with chronic experimental myocardial ischemia // J. Amer. Coll. Cardiol. - 2001. - Vol. 37. - P. 1726-1732.
32. Gasparovic H., Rybicki F., Millstine J. et al. Three dimensional computed tomographic imaging in planning the surgical approach for redo cardiac surgery after coronary revascularization // Eur. J. Cardiothorac. Surg. - 2005. - Vol. 28. - P. 244-249.
33. Gaudino M., Glieca F., Alessandrini F. et al. High risk coronary artery bypass patient: incidence, surgical strategies, and results // Ann. Thorac. Surg. - 2004. - Vol. 77. - P. 574-580.
34. Goodwin A. T., Ooi A., Kitcat J., Nashef S. Outcomes in emergency redo cardiac surgery: cost, benefit and risk assessment // Inter. Cardiovasc. Thorac. Surg. - 2003. - Vol. 2, № 3. - P. 227-230.
35. Gowdak L., Schettert I., Rochitte C. et al. Cell therapy plus transmyocardial laser revascularization for refractory angina // Ann. Thorac. Surg. - 2005. - Vol. 80. - P. 712-714.
36. Hirose H., Gill I., Lytle W. Redo-aortic valve replacement after previous bileateral internal thoracic artery bypass grafting // Ibid. - 2004. - Vol. 78. - P. 782-785.
37. Holzhey D., Jacobs S., Mochalski M. et al. Seven year follow-up after minimally invasive direct coronary artery bypass experience with more than 1300 patients // Ibid. - 2007. - Vol. 83. - P. 108-114.
38. Holzhey D., Jacobs S., Walther T. et al. Cumulative sum failure analysis for eight surgeons performing minimally invasive direct coronary artery bypass // J. Thorac. Cardiovasc. Surgery. - 2007. - Vol. 134, № 3. - P. 660-663.
39. Jalal A. An objective method for grading of distal disease in the grafted coronary arteries // Int. Cardiovasc. Thorac. Surg. - 2007. - Vol. 6 (Suppl. 3). - P. S278.
40. Kawamoto A., Gwon H., Iwaguro H. et al. Therapeutic potencial of ex vivo expanded endothelial progenitor cells for myocardial ischemia // Circulation. - 2001. - Vol. 103. - P. 634-637.
41. Keogh B. E., Kinsman R. The Society of Cardiothoracic Surgeons of Great Britain and Ireland. National Adult Cardiac Surgical Database Report, 2000-2001, 2002.
42. Kofidis T., Lebl D., Swijnenburg R. et al. Allopurinal/ uricase and ibuprofen enhance engrattment of cardiomyocyte - enriched human embryonic stem-cells and improve cardiac function following myocardial injury // Eur. J. Cardiothorac. Surg. - 2006. - Vol. 29, № 1. - P. 50-55.
43. Koh G., Soonpaa M., Klug M. et al. Long-term survival of AT-1 cardiomyocyte grafts in syngeneic myocardium // Amer. J. Physiol. - 1995. - Vol. 264 (Pt. 2). - P. H 1727-1733.
44. Kron J. Special considerations: redo coronary surgery. Presentation on the 21-st EACTS Annual Meteeng. - Geneva, sept. 19, 2007.
45. Macdonald D., Luo J., Saito T. et al. Persistence of marrow stromal cells implanted into acutely infracted myocardium: observations in a xenotransplant model // J. Thorac. Cardiovasc. Surg. - 2005. - Vol. 130. - P. 1114-1121.
46. Machiraju V. R. Review of redo cardiac surgery over the years. Presentation on the 21-st EACTS Annual Meteeng. - Geneva, sept. 19, 2007.
47. Makela J., Ylitalo K., Lehtonen S. et al. Bone marrow - derived mononuclear cell transplantation improves myocardial recovery by enhancing cellular recruitment and differentiation at the infarction site // J. Thorac. Cardiovasc. Surg. - 2007. - Vol. 134, № 3. - P. 565-572.
48. McNeil M., Buth K., Brydie A. et al. The impact of diffuseness of coronary artery disease on the outcomes of patients undergoing primary and reoperative coronary artery bypass grafting // Eur. J. Cardiothorac. Surg. - 2007. - Vol. 31, № 5. - P. 827-833.
49. Menasche P. Cell therapy in cardiac surgery: state of the art and where we headins? 5-th EACTS/ESTS, Joint Metting. Matherials of Postgraduate Courses. - Stockholm, Sweden, 2006. - P. 105.
50. Menasche P., Vilquin J., Desnos M. et al. Early results of autologous skeletal myoblast transplantation in patients with severe ischemic heart failure // Circulation. - 2002. - Vol. 105 (Suppl. 2). - P. 598.
51. Merlo C., Aidala E., La Scala E. et al. Mortality and morbidity in reoperation comparing to first intervention in coronary revascularization // J. Cardiovasc. Surg. (Torino). - 2001. - Vol. 42, № 6. - P. 713-717.
52. Miyaji K., Wolf R. K., Flege J. B. Jr. Minimally invasive direct coronary artery bypass for redo patients // Ann. Thorac. Surg. - 1999. - Vol. 67. - P. 1677-1681.
53. Noyez L., van Eck F. Long-term cardiac survival after reoperative coronary artery bypass grafting // Eur. J. Cardiothorac. Surg. - 2004. - Vol. 25, № 1. - P. 59-64.
54. Oh H., Bratfute S., Gallardo T. et al. Cardiac progenitors cells from adult myocardium: Homing, differentiation, and fusion after infarction // PNAS. - 2003. - Vol. 100, № 21. - P. 12313-12318.
55. Ohtsuka T., Ninomiya M., Nonaka T., Maemura T. Fluoroscopic angiography-guided mini-entry localization before minimally invasive redo coronary artery bypass // Inter. Cardiovasc. Thorac. Surg. - 2004. - Vol. 3, № 4. - P. 551-553.
56. Orlic D., Kajstura j., Chimenti S. et al. Mobilized bone marrow cells repair the infracted heart, improving function and survival // Proc. Natl. Acad. Sci. USA. - 2001. - Vol. 98. - P. 10344-10349.
57. Ozbaran M., Omay S., Nalbantgil S. et al. Autologous peripheral stem cell transplantation in patients with congestive heart failure due to ischemic heart disease // Eur. J. Cardiothorac. Surg. - 2004. - Vol. 25. - P. 342-351.
58. Perin E., Dohmann H., Borojevic R. et al. Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure // Circulation. - 2003. - Vol. 107. - P. 2294-2302.
59. Rastan A., Boudriot E., Folk V. et al. Frequency and multivessel and left main coronary artery diseaseinsights from a single-centre syntax study enrollment // Interact. Cardiovasc. Surg. - 2007. - Vol. 6 (Suppl. 3). - P. S244.
60. Rastan A., Walther T., Kostelka M. et al. Morphological, electrophysiological and coupling characteristics of bone marrow - derived mononuclear cells - on in vitro model // Eur. J. Cardiothorac. Surg. - 2005. - Vol. 27, № 1. - P. 104-106.
61. Roell W., Fan Y., Bloch W. et al. Transplantation of transgenic embryonic cardiomyocytes in mouse // 14-th Annual Meeting of the EACTS. Abstracts. - Frankfurt, 2000. - P. 504 (p. 204).
62. Sabik J. 3rd, Blackstone E., Houghtaling P. et al. Is reoperation still a risk factor in coronary artery bypass surgery? // Ann. Thorac. Surg. - 2005. - Vol. 80, № 5. - P. 1719-1727.
63. Sabik J. Dealing with the unexpected // Presentation on the 21-st EACTS Annual Meteeng. - Geneva, sept. 19, 2007.
64. Schachinger V., Erbs S., Elasser A. et al. Intracoronary bone-marrow derived progenitor cells in acute myocardial infarction // N. Engl. J. Med. - 2006. - Vol. 355. - P. 1210-1221.
65. Schachinger V., Tonn T., Dimmeler S. et al. Bonemarrow- derived progenitor cell therapy in need of proof of concept: design of the REPAIR-AMI trial // Nat. Clin. Pract. Cardiovasc. Med. - 2006. - Vol. 1 (Suppl. 1). - P. S23-S28.
66. Schmuziger M., Christenson J., Maurice J. et al. Myocardial revascularization for the second time. Analysis of 458 reoperations and 2645 single opertions // Cardiovasc. Surg. - 1994. - Vol. 2. - P. 623-629.
67. Shintani S., Murohara T., Ikeda H. et al. Augmentation of postnatal neovascularization with autologous bone marrow transplantation // Circulation. - 2001. - Vol. 103. - P. 897-903.
68. Siepe M. Stem cells used for cardiovascular tissue engineering // 21-st EACTS Annual Meeting Postgraduate courses. Book of proceedings. - Switzerland, Geneva, 2007. - P. 119-121.
69. Simons M., Ware A. Therapeutic angiogenesis in cardiovascular desease // J. Nat. Rev. - 2003. - Vol. 2. - P. 863-871.
70. Soonpaa M., Koh G., Klug M. et al. Formation of nascent intercalated disks between grafted fetal cardiomyocytes and host myocardium // Science. - 1994. - Vol. 264. - P. 98-101.
71. Stamou S., Pfister A., Dangas G. et al. Beating heart versus conventional single-vessel reoperative coronary artery bypass // Ann. Thorac. Surg. - 2000. - Vol. 69. - P. 1383-1387.
72. Tomita S., Mickle D., Weisel R. et al. Improved heart function with myogenesis and angiogenesis following autologous poreine bone marrow stromal cell transplantation // J. Thorac. Cardiovasc. Surg. - 2002. - Vol. 123. - P. 1132-1140.
73. Trehan N., Mishra Y., Malhotra R. et al. Off-pump redo coronary artery bypass grafting // Ann. Thorac. Surg. - 2000. - Vol. 70. - P. 1026-1029.
74. Tse H., Kwong Y., Chan J. et al. Angiogenesis in ischemic myocardium by intramyocardial autologous bone marrow mononuclear cell implantation // Lancet. - 2003. - Vol. 361. - P. 47-49.
75. Weber A., Pedrosa I., Kawamoto A. et al. Magnetic resonance mapping of transplanted endothelial progenitor cells for therapeutic neovascularization in ischemic heart disease // Eur. J. Cardiothorac. Surg. - 2004. - Vol. 26. - P. 137-143.
76. Weisel R., Li R., Mickle D. et al. Cell transplantation comes of Age // J. Thorac. Cardiovasc. Surg. - 2001. - Vol. 121. - P. 835-836.
77. Xiao Y., Min J., Morgan J. et al. Immunosuppression and xenotransplantation of cells for cardiac repair // Ann. Thorac. Surg. - 2004. - Vol. 77, № 2. - P. 737-744.
78. Yee A., Rosengart T. Angiogenesis and Gene Therapy for the Treatment of Coronary Artery Desease // Advanced therapy in cardiac surgery. - Ch. 16. / Eds K. L. Franco, E. D. Verrier. - London: BC Decker Inc, 2003. - P. 138-146.
79. Zhang S., Zhang P., Guo J. et al. Enhanced cytoprotection and angiogenesis by bone marrow cell transplantation may contribute to improved ischemic myocardial function // Eur. J. Cardio